FDG PET/CT

You have access
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
Martin Schuler, Jörg Hense, Kaid Darwiche, Sebastian Michels, Hubertus Hautzel, Carsten Kobe, Smiths Lueong, Martin Metzenmacher, Thomas Herold, Gregor Zaun, Katharina Laue, Alexander Drzezga, Dirk Theegarten, Felix Nensa, Jürgen Wolf, Ken Herrmann and Marcel Wiesweg

Journal of Nuclear Medicine June 1, 2024, 65 (6) 851-855; DOI: https://doi.org/10.2967/jnumed.123.266979
Open Access
ChatGPT: Can You Prepare My Patients for [¹⁸F]FDG PET/CT and Explain My Reports?
Julian M.M. Rogasch, Giulia Metzger, Martina Preisler, Markus Galler, Felix Thiele, Winfried Brenner, Felix Feldhaus, Christoph Wetz, Holger Amthauer, Christian Furth and Imke Schatka

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1876-1879; DOI: https://doi.org/10.2967/jnumed.123.266114
You have access
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
Maeve A. Hennessy, Jeffrey P. Leal, Chiung-Yu Huang, Lilja B. Solnes, Rita Denbow, Vandana G. Abramson, Lisa A. Carey, Minetta C. Liu, Mothaffar Rimawi, Jennifer Specht, Anna Maria Storniolo, Vicente Valero, Christos Vaklavas, Eric P. Winer, Ian E. Krop, Antonio C. Wolff, Ashley Cimino-Mathews, Richard L. Wahl, Vered Stearns and Roisin M. Connolly

Journal of Nuclear Medicine November 1, 2023, 64 (11) 1690-1696; DOI: https://doi.org/10.2967/jnumed.123.265853
You have access
¹⁸F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack and Val J. Lowe

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1887-1890; DOI: https://doi.org/10.2967/jnumed.122.263902
You have access
PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results
Juliano J. Cerci, Mateos Bogoni, Rodrigo J. Cerci, Margaret Masukawa, Carlos C.P. Neto, Cassiano Krauzer, Stefano Fanti, Danielle G. Sakamoto, Renan B. Barreiros, Cristina Nanni and João V Vitola

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1057-1061; DOI: https://doi.org/10.2967/jnumed.120.252403
You have access
What ¹⁸F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball and Michael P. Mac Manus

Journal of Nuclear Medicine March 1, 2019, 60 (3) 328-334; DOI: https://doi.org/10.2967/jnumed.118.214148
You have access
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as ¹⁸F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Alain Hendlisz, Lieveke Ameye, Camilo Garcia, Tarek Kamoun, Thomas Guiot, Marianne Paesmans and Patrick Flamen

Journal of Nuclear Medicine February 1, 2019, 60 (2) 178-184; DOI: https://doi.org/10.2967/jnumed.118.210161
You have access
¹⁸F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
Joan Fledelius, Anne Winther-Larsen, Azza A. Khalil, Catharina M. Bylov, Karin Hjorthaug, Aksel Bertelsen, Jørgen Frøkiær and Peter Meldgaard

Journal of Nuclear Medicine December 1, 2017, 58 (12) 1931-1937; DOI: https://doi.org/10.2967/jnumed.117.193003
You have access
Does Antibiotic Treatment Affect the Diagnostic Accuracy of ¹⁸F-FDG PET/CT Studies in Patients with Suspected Infectious Processes?
Olga Kagna, Marina Kurash, Nesrin Ghanem-Zoubi, Zohar Keidar and Ora Israel

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1827-1830; DOI: https://doi.org/10.2967/jnumed.117.192062
You have access
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational ¹⁸F-FDG PET/CT Observation
Matteo Bauckneht, Giulia Ferrarazzo, Francesco Fiz, Silvia Morbelli, Matteo Sarocchi, Fabio Pastorino, Alberto Ghidella, Elena Pomposelli, Maurizio Miglino, Pietro Ameri, Laura Emionite, Flavia Ticconi, Eleonora Arboscello, Ambra Buschiazzo, Elena Augusta Massimelli, Salvatore Fiordoro, Anna Borra, Vanessa Cossu, Annalisa Bozzano, Adalberto Ibatici, Mirco Ponzoni, Paolo Spallarossa, Andrea Gallamini, Paolo Bruzzi, Gianmario Sambuceti and Cecilia Marini

Journal of Nuclear Medicine October 1, 2017, 58 (10) 1638-1645; DOI: https://doi.org/10.2967/jnumed.117.191122

Main menu

User menu

Search

FDG PET/CT

Pages